How Active Surveillance for Prostate Cancer Can Fail Since the introduction of the prostate specific antigen (PSA) test in the early 1990’s, the medical community has struggled with the issue of over treatment of prostate cancer. The PSA test detects many low-risk prostate cancers that do not immediate treatment. The treatment protocol for these cancer is called ‘active surveillance (AS).’ The introduction of AS alleviated a good deal of the over treatment but, as the article below shows, men and their doctors need to follow the treatment regimen. When there’s no treatment, it’s easy to forget and the cancer might just turn aggressive. If you are following an active surveillance program, we suggest that you personally track your PSA test with ProstateTracker. Once you create your ProstateTracker account, you will receive an email reminder every 12 months that it’s time for your next PSA test. This reminder serves as that proverbial ‘string around your finger.’ Read the full article below: Prostate Cancer: ‘Active’ Surveillance Is Often ‘Not’ by: Kate Johnson May 09, 2016 SAN DIEGO, California — Only 1 in 3 men with low-risk prostate cancer receive appropriate follow-up when assigned to active surveillance (AS) of their disease, a new study suggests. The findings […]
read more